Skip to content

ULTRAGENYX PHARMACEUTICAL INC.: filings

Every ULTRAGENYX PHARMACEUTICAL INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026411130001193125-26-333233
10-Q2026-05-06fiscal Q1 202639810001193125-26-206960
10-K2026-02-18fiscal FY 2025511230001193125-26-057329
10-Q2025-11-05fiscal Q3 2025411130001193125-25-265126
10-Q2025-08-06fiscal Q2 2025411130000950170-25-103290
10-Q2025-05-07fiscal Q1 202541850000950170-25-064726
10-K2025-02-19fiscal FY 2024501240000950170-25-023312
10-Q2024-11-06fiscal Q3 2024401110000950170-24-121679
10-Q2024-08-02fiscal Q2 2024401110000950170-24-089488
10-Q2024-05-03fiscal Q1 202440830000950170-24-052346
10-K2024-02-21fiscal FY 2023491210000950170-24-017879
10-Q2023-11-03fiscal Q3 2023421150000950170-23-058427
10-Q2023-08-04fiscal Q2 2023421150000950170-23-038173
10-Q2023-05-05fiscal Q1 202342870000950170-23-018017
10-K2023-02-17fiscal FY 2022511250000950170-23-003096
10-Q2022-11-03fiscal Q3 2022421150000950170-22-021366
10-Q2022-07-29fiscal Q2 2022391030000950170-22-013411
10-Q2022-05-06fiscal Q1 202239830000950170-22-007940
10-K2022-02-15fiscal FY 2021471100000950170-22-001284
10-Q2021-11-03fiscal Q3 202138990000950170-21-002687
10-Q2021-08-03fiscal Q2 2021441220001564590-21-039879
10-Q2021-05-05fiscal Q1 202140840001564590-21-023501
10-K2021-02-12fiscal FY 2020501470001564590-21-005610
10-Q2020-10-27fiscal Q3 2020411060001564590-20-047991
10-Q2020-07-30fiscal Q2 2020451220001564590-20-035082
10-Q2020-05-07fiscal Q1 202040820001564590-20-022136
10-K2020-02-14fiscal FY 2019501440001564590-20-004667
10-Q2019-11-06fiscal Q3 2019441100001564590-19-040541
10-Q2019-08-02fiscal Q2 2019441110001564590-19-028087
10-Q2019-05-07fiscal Q1 201948950001564590-19-016079
10-K2019-02-20fiscal FY 2018471380001564590-19-003324
10-Q2018-11-06fiscal Q3 201839960001564590-18-026944
10-Q2018-08-03fiscal Q2 2018401000001564590-18-018979
10-Q2018-05-08fiscal Q1 201839790001564590-18-011341
10-K2018-02-21fiscal FY 2017381020001564590-18-002535
10-Q2017-11-03fiscal Q3 201730800001564590-17-021336
10-Q2017-07-28fiscal Q2 201730800001564590-17-014324
10-Q2017-05-05fiscal Q1 201728580001564590-17-008895
10-K2017-02-17fiscal FY 2016351030001564590-17-001714
10-Q2016-11-08fiscal Q3 201629760001564590-16-028043
10-Q2016-08-09fiscal Q2 201629760001564590-16-023403
10-Q2016-05-10fiscal Q1 201629600001564590-16-018694
10-K2016-02-26fiscal FY 2015351140001564590-16-013430
10-Q2015-11-10fiscal Q3 201530800001564590-15-010240
10-Q2015-08-14fiscal Q2 201531840001564590-15-007307
10-Q2015-05-12fiscal Q1 201531640001564590-15-003978
10-K2015-03-27fiscal FY 2014341100001564590-15-002066
10-Q2014-11-10fiscal Q3 201434890001564590-14-005413
10-Q2014-08-11fiscal Q2 201433850001564590-14-003472
10-Q2014-05-12fiscal Q1 201434830001564590-14-002047

Inspect the source

Entity
ULTRAGENYX PHARMACEUTICAL INC. / CIK 0001515673
Captured
2026-09-20T09:13:41.216Z
SEC response SHA-256
3388baa10c986fcc5de3f265870d6dbd0a3e1dda1bcd7ba6dcbc8c72254b9c41

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001515673.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))